| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serine Endopeptidases | 49 | 2006 | 150 | 3.220 |
Why?
|
| Granzymes | 67 | 2017 | 96 | 3.180 |
Why?
|
| Perforin | 36 | 2014 | 56 | 2.210 |
Why?
|
| Apoptosis | 43 | 2015 | 1756 | 2.210 |
Why?
|
| T-Lymphocytes, Cytotoxic | 26 | 2015 | 320 | 1.460 |
Why?
|
| Membrane Glycoproteins | 25 | 2005 | 454 | 1.420 |
Why?
|
| Cytoplasmic Granules | 15 | 2009 | 95 | 1.420 |
Why?
|
| Cell Membrane | 13 | 2014 | 687 | 1.250 |
Why?
|
| Cytotoxicity, Immunologic | 29 | 2009 | 218 | 1.130 |
Why?
|
| Killer Cells, Natural | 24 | 2014 | 292 | 1.030 |
Why?
|
| Caspases | 18 | 2009 | 156 | 0.760 |
Why?
|
| Pore Forming Cytotoxic Proteins | 28 | 2015 | 54 | 0.740 |
Why?
|
| Jurkat Cells | 22 | 2014 | 84 | 0.710 |
Why?
|
| Cell Membrane Permeability | 6 | 2014 | 121 | 0.600 |
Why?
|
| Proteoglycans | 8 | 2005 | 126 | 0.560 |
Why?
|
| Flow Cytometry | 12 | 2005 | 726 | 0.440 |
Why?
|
| Lymphocytes | 6 | 2004 | 465 | 0.440 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 108 | 0.410 |
Why?
|
| Interleukin-6 | 4 | 2008 | 281 | 0.400 |
Why?
|
| Mitochondria | 7 | 2015 | 621 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2017 | 712 | 0.360 |
Why?
|
| Cysteine Endopeptidases | 7 | 2006 | 90 | 0.360 |
Why?
|
| Phosphatidylserines | 1 | 2011 | 21 | 0.350 |
Why?
|
| Arthritis, Rheumatoid | 10 | 2017 | 187 | 0.340 |
Why?
|
| Interleukin-2 | 9 | 1993 | 246 | 0.330 |
Why?
|
| Caspase 3 | 13 | 2015 | 164 | 0.300 |
Why?
|
| Interleukin-1beta | 2 | 2011 | 89 | 0.300 |
Why?
|
| Killer Cells, Lymphokine-Activated | 7 | 2004 | 27 | 0.280 |
Why?
|
| Lymphocyte Activation | 13 | 2004 | 810 | 0.280 |
Why?
|
| Fibroblasts | 7 | 2015 | 777 | 0.280 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2008 | 211 | 0.280 |
Why?
|
| Humans | 101 | 2014 | 96004 | 0.250 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2012 | 667 | 0.250 |
Why?
|
| Cytokines | 3 | 2014 | 871 | 0.240 |
Why?
|
| Enzyme Precursors | 3 | 2003 | 20 | 0.240 |
Why?
|
| Extracellular Space | 3 | 2011 | 90 | 0.240 |
Why?
|
| Endocytosis | 5 | 2011 | 186 | 0.230 |
Why?
|
| Exocytosis | 5 | 2011 | 110 | 0.230 |
Why?
|
| Cell Death | 5 | 2009 | 264 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 19 | 2002 | 1046 | 0.230 |
Why?
|
| T-Lymphocytes | 5 | 2004 | 1310 | 0.230 |
Why?
|
| HeLa Cells | 8 | 2011 | 522 | 0.230 |
Why?
|
| Animals | 40 | 2017 | 28916 | 0.220 |
Why?
|
| Lupus Erythematosus, Systemic | 9 | 1990 | 235 | 0.210 |
Why?
|
| Mice | 26 | 2017 | 12537 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2015 | 684 | 0.200 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2009 | 59 | 0.200 |
Why?
|
| Lymphocytic choriomeningitis virus | 3 | 2012 | 16 | 0.200 |
Why?
|
| Lipid Bilayers | 3 | 2014 | 147 | 0.200 |
Why?
|
| Neutrophils | 1 | 2004 | 328 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2008 | 207 | 0.190 |
Why?
|
| Serpins | 4 | 2006 | 31 | 0.180 |
Why?
|
| Arenaviridae Infections | 2 | 2012 | 4 | 0.180 |
Why?
|
| Membrane Proteins | 5 | 2015 | 1275 | 0.180 |
Why?
|
| Macrophages | 5 | 2014 | 623 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2010 | 509 | 0.170 |
Why?
|
| Cell Line | 14 | 2015 | 2536 | 0.170 |
Why?
|
| Monocytes | 3 | 2013 | 220 | 0.170 |
Why?
|
| Enzyme Activation | 11 | 2008 | 692 | 0.170 |
Why?
|
| fas Receptor | 7 | 2004 | 76 | 0.170 |
Why?
|
| Glycosaminoglycans | 2 | 2005 | 49 | 0.160 |
Why?
|
| Carrier Proteins | 5 | 2004 | 682 | 0.160 |
Why?
|
| Rosette Formation | 5 | 1983 | 29 | 0.150 |
Why?
|
| Models, Biological | 8 | 2011 | 1810 | 0.150 |
Why?
|
| Calcium | 5 | 2011 | 1205 | 0.150 |
Why?
|
| Cells, Cultured | 15 | 2014 | 2929 | 0.150 |
Why?
|
| Signal Transduction | 8 | 2009 | 3581 | 0.140 |
Why?
|
| Cartilage | 2 | 2001 | 116 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 11 | 2010 | 1425 | 0.140 |
Why?
|
| Substrate Specificity | 6 | 2008 | 368 | 0.140 |
Why?
|
| Cattle | 5 | 2011 | 401 | 0.140 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 2002 | 46 | 0.140 |
Why?
|
| Peptide Fragments | 3 | 2010 | 477 | 0.140 |
Why?
|
| Chromatography, Affinity | 2 | 2000 | 84 | 0.140 |
Why?
|
| Secretory Vesicles | 2 | 2011 | 43 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2005 | 380 | 0.130 |
Why?
|
| Research Design | 1 | 2001 | 630 | 0.130 |
Why?
|
| Interleukin-8 | 2 | 1996 | 88 | 0.130 |
Why?
|
| Arthritis, Experimental | 1 | 2017 | 27 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2004 | 266 | 0.120 |
Why?
|
| Vesicular Transport Proteins | 4 | 2005 | 70 | 0.120 |
Why?
|
| Protein Binding | 6 | 2014 | 1560 | 0.120 |
Why?
|
| Immunoglobulin G | 8 | 1997 | 481 | 0.120 |
Why?
|
| Membrane Lipids | 2 | 2014 | 41 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2015 | 204 | 0.110 |
Why?
|
| Necrosis | 2 | 2014 | 212 | 0.110 |
Why?
|
| Cell Nucleus | 6 | 2001 | 618 | 0.110 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 3 | 1984 | 41 | 0.110 |
Why?
|
| Protein Conformation | 4 | 2012 | 935 | 0.110 |
Why?
|
| Protein Transport | 2 | 2014 | 439 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2017 | 277 | 0.110 |
Why?
|
| Esterases | 1 | 1994 | 13 | 0.110 |
Why?
|
| Carboxypeptidases | 1 | 1994 | 34 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 3 | 2013 | 256 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2010 | 307 | 0.110 |
Why?
|
| Amino Acid Sequence | 8 | 2012 | 2090 | 0.110 |
Why?
|
| Cell Line, Tumor | 7 | 2010 | 2778 | 0.110 |
Why?
|
| Caspase 1 | 3 | 2006 | 20 | 0.110 |
Why?
|
| Kinetics | 10 | 2002 | 1561 | 0.110 |
Why?
|
| B-Lymphocytes | 3 | 1987 | 760 | 0.100 |
Why?
|
| Cell Separation | 3 | 1984 | 205 | 0.100 |
Why?
|
| Epitopes | 2 | 2011 | 258 | 0.100 |
Why?
|
| Autoantibodies | 3 | 1990 | 281 | 0.100 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 2 | 2004 | 14 | 0.100 |
Why?
|
| Receptor, IGF Type 2 | 2 | 2004 | 7 | 0.100 |
Why?
|
| Cell Adhesion | 4 | 2008 | 430 | 0.100 |
Why?
|
| Glycoproteins | 1 | 1994 | 231 | 0.100 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 3040 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2014 | 1376 | 0.100 |
Why?
|
| Propidium | 2 | 2011 | 6 | 0.100 |
Why?
|
| Caspase 7 | 4 | 2003 | 15 | 0.100 |
Why?
|
| Models, Immunological | 2 | 2004 | 85 | 0.100 |
Why?
|
| DNA Fragmentation | 6 | 2004 | 65 | 0.100 |
Why?
|
| Bacteremia | 1 | 2014 | 108 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1993 | 130 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 163 | 0.100 |
Why?
|
| Adenoviridae | 4 | 2008 | 342 | 0.100 |
Why?
|
| Hydrolysis | 4 | 2005 | 146 | 0.100 |
Why?
|
| Mycobacterium | 1 | 2013 | 19 | 0.100 |
Why?
|
| Sheep | 2 | 2011 | 250 | 0.100 |
Why?
|
| Receptors, Fc | 2 | 1984 | 40 | 0.100 |
Why?
|
| Cytotoxins | 1 | 2012 | 17 | 0.100 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2012 | 21 | 0.100 |
Why?
|
| Inflammation | 2 | 2009 | 1064 | 0.090 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2012 | 11 | 0.090 |
Why?
|
| Poloxalene | 1 | 1992 | 8 | 0.090 |
Why?
|
| Serine Proteinase Inhibitors | 4 | 2003 | 26 | 0.090 |
Why?
|
| Annexin A5 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Thrombin | 3 | 1996 | 61 | 0.090 |
Why?
|
| Cytoskeleton | 2 | 2010 | 200 | 0.090 |
Why?
|
| Ions | 1 | 2011 | 79 | 0.090 |
Why?
|
| beta-Endorphin | 3 | 1987 | 11 | 0.090 |
Why?
|
| Antibody Specificity | 4 | 1998 | 128 | 0.090 |
Why?
|
| Recombinant Proteins | 8 | 2011 | 1006 | 0.080 |
Why?
|
| Polyradiculoneuropathy | 2 | 1981 | 8 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2013 | 220 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 290 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2004 | 796 | 0.080 |
Why?
|
| Extracellular Matrix | 3 | 2005 | 255 | 0.080 |
Why?
|
| DNA Damage | 3 | 2009 | 392 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2011 | 464 | 0.080 |
Why?
|
| Biological Transport | 5 | 2005 | 412 | 0.080 |
Why?
|
| Gelsolin | 1 | 2010 | 11 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 32 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 3491 | 0.080 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 1990 | 3 | 0.080 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1990 | 20 | 0.080 |
Why?
|
| Time Factors | 3 | 2011 | 5594 | 0.080 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2001 | 96 | 0.080 |
Why?
|
| Mitogens | 2 | 1987 | 60 | 0.080 |
Why?
|
| Cytotoxicity Tests, Immunologic | 5 | 1996 | 45 | 0.080 |
Why?
|
| Cholesterol | 1 | 2011 | 367 | 0.080 |
Why?
|
| K562 Cells | 3 | 2009 | 49 | 0.070 |
Why?
|
| U937 Cells | 1 | 2008 | 32 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1989 | 47 | 0.070 |
Why?
|
| Chlamydia trachomatis | 1 | 2008 | 16 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2008 | 462 | 0.070 |
Why?
|
| Unilamellar Liposomes | 1 | 2008 | 5 | 0.070 |
Why?
|
| Chlamydia Infections | 1 | 2008 | 32 | 0.070 |
Why?
|
| Uveal Neoplasms | 1 | 2008 | 11 | 0.070 |
Why?
|
| Streptolysins | 3 | 2008 | 5 | 0.070 |
Why?
|
| Tubulin | 1 | 2008 | 61 | 0.070 |
Why?
|
| Deltaretrovirus | 1 | 1987 | 2 | 0.070 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1987 | 73 | 0.070 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1988 | 69 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 2 | 2010 | 48 | 0.070 |
Why?
|
| Mice, Knockout | 6 | 2012 | 2161 | 0.070 |
Why?
|
| Microtubules | 1 | 2008 | 134 | 0.070 |
Why?
|
| Endorphins | 2 | 1984 | 13 | 0.070 |
Why?
|
| Antilymphocyte Serum | 4 | 1983 | 69 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2008 | 226 | 0.070 |
Why?
|
| DNA Repair | 1 | 2009 | 376 | 0.070 |
Why?
|
| Permeability | 2 | 2005 | 144 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 187 | 0.060 |
Why?
|
| Cell Survival | 4 | 2004 | 1029 | 0.060 |
Why?
|
| Cytosol | 4 | 1999 | 197 | 0.060 |
Why?
|
| In Vitro Techniques | 5 | 1996 | 1014 | 0.060 |
Why?
|
| Phylogeny | 1 | 2012 | 1277 | 0.060 |
Why?
|
| Lipids | 1 | 2008 | 285 | 0.060 |
Why?
|
| Ultracentrifugation | 3 | 2002 | 43 | 0.060 |
Why?
|
| Lymphokines | 1 | 1986 | 75 | 0.060 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 3 | 2015 | 41 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 750 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 4 | 2011 | 443 | 0.060 |
Why?
|
| Scattering, Radiation | 2 | 2002 | 123 | 0.060 |
Why?
|
| Biotinylation | 2 | 2002 | 42 | 0.060 |
Why?
|
| Vitronectin | 1 | 2005 | 5 | 0.060 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2005 | 21 | 0.060 |
Why?
|
| Oligopeptides | 2 | 1998 | 193 | 0.060 |
Why?
|
| Transfection | 6 | 2004 | 908 | 0.060 |
Why?
|
| Epithelium | 2 | 1996 | 322 | 0.060 |
Why?
|
| Biological Assay | 1 | 2005 | 84 | 0.060 |
Why?
|
| WT1 Proteins | 1 | 2004 | 21 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 96 | 0.050 |
Why?
|
| Laminin | 1 | 2005 | 92 | 0.050 |
Why?
|
| Viruses | 1 | 2005 | 75 | 0.050 |
Why?
|
| Biomarkers | 1 | 2011 | 1931 | 0.050 |
Why?
|
| Fibronectins | 1 | 2005 | 100 | 0.050 |
Why?
|
| Membrane Potentials | 2 | 2003 | 442 | 0.050 |
Why?
|
| Liver | 2 | 2014 | 1231 | 0.050 |
Why?
|
| Arthritis, Juvenile | 2 | 1981 | 32 | 0.050 |
Why?
|
| Breast Neoplasms | 5 | 2004 | 3155 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 54 | 0.050 |
Why?
|
| Aging | 2 | 1990 | 766 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2003 | 36 | 0.050 |
Why?
|
| Melanoma | 1 | 2008 | 495 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 3 | 2000 | 113 | 0.050 |
Why?
|
| Caspase 9 | 5 | 2004 | 49 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2004 | 188 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2003 | 56 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2001 | 291 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2001 | 113 | 0.050 |
Why?
|
| Electrophoresis, Capillary | 1 | 2002 | 11 | 0.050 |
Why?
|
| Spleen | 3 | 2014 | 420 | 0.050 |
Why?
|
| Sepharose | 1 | 2002 | 14 | 0.050 |
Why?
|
| Lysosomes | 1 | 2003 | 124 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 89 | 0.050 |
Why?
|
| Chondroitin Sulfates | 1 | 2002 | 43 | 0.050 |
Why?
|
| Lasers | 1 | 2002 | 102 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2002 | 126 | 0.050 |
Why?
|
| Synovial Fluid | 2 | 1999 | 11 | 0.050 |
Why?
|
| Biophysics | 1 | 2002 | 157 | 0.050 |
Why?
|
| Endosomes | 2 | 1999 | 86 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 1966 | 0.050 |
Why?
|
| Microscopy, Confocal | 5 | 2004 | 286 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 1999 | 179 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 3 | 1999 | 416 | 0.050 |
Why?
|
| Homeostasis | 1 | 2004 | 467 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1982 | 26 | 0.040 |
Why?
|
| Caspase Inhibitors | 1 | 2001 | 32 | 0.040 |
Why?
|
| Cardiolipins | 3 | 1991 | 17 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2002 | 81 | 0.040 |
Why?
|
| HIV-1 | 2 | 2000 | 182 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2003 | 289 | 0.040 |
Why?
|
| Nuclear Envelope | 2 | 1998 | 39 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1990 | 326 | 0.040 |
Why?
|
| Light | 1 | 2002 | 297 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2004 | 350 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 34 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2001 | 95 | 0.040 |
Why?
|
| Fas Ligand Protein | 4 | 2002 | 50 | 0.040 |
Why?
|
| Caspase 8 | 4 | 2004 | 35 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2001 | 31 | 0.040 |
Why?
|
| Nephrosis, Lipoid | 1 | 1980 | 6 | 0.040 |
Why?
|
| Glucose | 1 | 2004 | 702 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 103 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2015 | 25 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 547 | 0.040 |
Why?
|
| Simplexvirus | 1 | 2001 | 150 | 0.040 |
Why?
|
| Hemolysis | 2 | 2000 | 63 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2004 | 353 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 2004 | 108 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2001 | 235 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2001 | 163 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2001 | 109 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2003 | 469 | 0.040 |
Why?
|
| Etoposide | 1 | 2001 | 207 | 0.040 |
Why?
|
| Naphthoquinones | 1 | 2000 | 8 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 2 | 2011 | 115 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2000 | 72 | 0.040 |
Why?
|
| Hemolysin Proteins | 1 | 1999 | 34 | 0.040 |
Why?
|
| Rheumatoid Factor | 2 | 1997 | 26 | 0.040 |
Why?
|
| Penicillamine | 1 | 1979 | 12 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 1999 | 115 | 0.040 |
Why?
|
| Receptors, Thrombin | 2 | 1996 | 3 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 562 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2015 | 358 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 1999 | 183 | 0.040 |
Why?
|
| Cell Fractionation | 2 | 2000 | 71 | 0.040 |
Why?
|
| Myasthenia Gravis | 1 | 1979 | 83 | 0.040 |
Why?
|
| Software | 1 | 2002 | 698 | 0.030 |
Why?
|
| Bacterial Proteins | 4 | 2008 | 922 | 0.030 |
Why?
|
| Organophosphonates | 1 | 1998 | 53 | 0.030 |
Why?
|
| HIV Infections | 3 | 2003 | 974 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 1996 | 122 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1998 | 69 | 0.030 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1997 | 16 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 303 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 223 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 366 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1980 | 355 | 0.030 |
Why?
|
| Subcellular Fractions | 2 | 2010 | 95 | 0.030 |
Why?
|
| Culture Media | 2 | 1989 | 149 | 0.030 |
Why?
|
| Amino Acids | 1 | 1998 | 262 | 0.030 |
Why?
|
| Rabbits | 2 | 2000 | 639 | 0.030 |
Why?
|
| Cobalt | 1 | 1996 | 31 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1996 | 52 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 587 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2000 | 488 | 0.030 |
Why?
|
| Helminth Proteins | 1 | 1996 | 14 | 0.030 |
Why?
|
| DNA | 2 | 1994 | 1329 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1998 | 396 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 1997 | 75 | 0.030 |
Why?
|
| RNA, Viral | 1 | 1997 | 311 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1998 | 208 | 0.030 |
Why?
|
| Binding Sites | 3 | 2006 | 1167 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2005 | 1124 | 0.030 |
Why?
|
| Female | 15 | 2017 | 49981 | 0.030 |
Why?
|
| Cell Compartmentation | 2 | 2010 | 70 | 0.030 |
Why?
|
| Cathepsin A | 1 | 1994 | 2 | 0.030 |
Why?
|
| Calcimycin | 1 | 1994 | 33 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 28 | 0.030 |
Why?
|
| Colicins | 1 | 2014 | 1 | 0.030 |
Why?
|
| Melitten | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cathepsins | 1 | 1994 | 22 | 0.030 |
Why?
|
| Antibodies | 2 | 2001 | 356 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2010 | 2089 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2015 | 766 | 0.030 |
Why?
|
| Brucella | 1 | 2014 | 4 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2008 | 526 | 0.030 |
Why?
|
| Male | 14 | 2004 | 45801 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 124 | 0.030 |
Why?
|
| Hypotonic Solutions | 1 | 1993 | 8 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 33 | 0.030 |
Why?
|
| Aggrecans | 1 | 1993 | 43 | 0.030 |
Why?
|
| Detergents | 1 | 1993 | 33 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2008 | 740 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 342 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 1993 | 89 | 0.030 |
Why?
|
| Rats | 4 | 2002 | 4155 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 2 | 1998 | 125 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2013 | 77 | 0.020 |
Why?
|
| Skin | 1 | 1996 | 604 | 0.020 |
Why?
|
| Adult | 13 | 1999 | 28637 | 0.020 |
Why?
|
| Apicomplexa | 1 | 2012 | 5 | 0.020 |
Why?
|
| Interferon Type I | 2 | 1984 | 171 | 0.020 |
Why?
|
| Polymerization | 1 | 2012 | 36 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 897 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 1192 | 0.020 |
Why?
|
| Splenomegaly | 1 | 2012 | 23 | 0.020 |
Why?
|
| Retinal Vein Occlusion | 2 | 1989 | 6 | 0.020 |
Why?
|
| Hepatitis | 1 | 2012 | 35 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 111 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1992 | 103 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1992 | 117 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 360 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 750 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1992 | 297 | 0.020 |
Why?
|
| Nasal Septum | 1 | 1991 | 27 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2005 | 431 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 1992 | 68 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 1991 | 54 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1991 | 100 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 1995 | 705 | 0.020 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 2002 | 165 | 0.020 |
Why?
|
| Receptors, IgG | 2 | 2001 | 68 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2011 | 14 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2005 | 1645 | 0.020 |
Why?
|
| Cartilage, Articular | 1 | 1991 | 78 | 0.020 |
Why?
|
| Proteins | 1 | 1996 | 816 | 0.020 |
Why?
|
| Peptides | 2 | 2004 | 671 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 241 | 0.020 |
Why?
|
| Egtazic Acid | 2 | 2004 | 33 | 0.020 |
Why?
|
| Bone Marrow Cells | 2 | 2004 | 270 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2010 | 22 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 117 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2010 | 8 | 0.020 |
Why?
|
| Tetracycline | 1 | 2010 | 13 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1990 | 29 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 1990 | 9 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2010 | 90 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 161 | 0.020 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 1990 | 6 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2003 | 288 | 0.020 |
Why?
|
| Liposomes | 1 | 2010 | 101 | 0.020 |
Why?
|
| Virus Replication | 2 | 2003 | 326 | 0.020 |
Why?
|
| Cocaine | 1 | 1991 | 81 | 0.020 |
Why?
|
| Chromatography, Gel | 2 | 2000 | 105 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 1990 | 37 | 0.020 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 30 | 0.020 |
Why?
|
| Anemia, Pernicious | 1 | 1989 | 2 | 0.020 |
Why?
|
| Lung | 1 | 1996 | 1381 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 1990 | 97 | 0.020 |
Why?
|
| Sudden Infant Death | 1 | 1990 | 34 | 0.020 |
Why?
|
| Scleroderma, Systemic | 1 | 1990 | 59 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 1990 | 122 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 129 | 0.020 |
Why?
|
| Caspase 10 | 2 | 1998 | 5 | 0.020 |
Why?
|
| Autoantigens | 1 | 1990 | 139 | 0.020 |
Why?
|
| Plasma | 1 | 1989 | 51 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 336 | 0.020 |
Why?
|
| Octoxynol | 1 | 2008 | 8 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 517 | 0.020 |
Why?
|
| Prednisone | 1 | 1989 | 252 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 1988 | 21 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1987 | 19 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 302 | 0.020 |
Why?
|
| Receptors, Opioid | 1 | 1987 | 23 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 1827 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1987 | 75 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 223 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 1996 | 189 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2001 | 644 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 206 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 284 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 2385 | 0.020 |
Why?
|
| Immunoglobulin M | 3 | 1997 | 164 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 227 | 0.020 |
Why?
|
| DNA Replication | 1 | 1988 | 177 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2006 | 27 | 0.020 |
Why?
|
| Chymases | 2 | 1998 | 10 | 0.020 |
Why?
|
| Phenotype | 2 | 1983 | 2577 | 0.020 |
Why?
|
| Phospholipids | 1 | 1987 | 110 | 0.020 |
Why?
|
| Isocoumarins | 2 | 1997 | 7 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1987 | 151 | 0.020 |
Why?
|
| Coumarins | 2 | 1997 | 14 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 101 | 0.020 |
Why?
|
| Pyruvates | 1 | 1986 | 13 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1991 | 451 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 1986 | 13 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1986 | 39 | 0.020 |
Why?
|
| Indomethacin | 1 | 1986 | 62 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1987 | 84 | 0.010 |
Why?
|
| Gene Expression | 1 | 2009 | 1319 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1983 | 148 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2005 | 26 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1985 | 32 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2008 | 385 | 0.010 |
Why?
|
| Sulfates | 1 | 2005 | 59 | 0.010 |
Why?
|
| Static Electricity | 1 | 2005 | 97 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2536 | 0.010 |
Why?
|
| CHO Cells | 1 | 2005 | 196 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 112 | 0.010 |
Why?
|
| Chromium | 1 | 2004 | 17 | 0.010 |
Why?
|
| Macrolides | 1 | 2004 | 31 | 0.010 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2004 | 11 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 2004 | 48 | 0.010 |
Why?
|
| Neoplasms | 2 | 2015 | 3242 | 0.010 |
Why?
|
| Protein Hydrolysates | 1 | 1984 | 9 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 102 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 171 | 0.010 |
Why?
|
| Cricetinae | 1 | 2005 | 542 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 2004 | 3 | 0.010 |
Why?
|
| Acidosis | 1 | 1984 | 56 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 28 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 139 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1984 | 35 | 0.010 |
Why?
|
| Thymidine | 1 | 2004 | 59 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2004 | 118 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 1984 | 64 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 548 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 279 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 282 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1983 | 50 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 648 | 0.010 |
Why?
|
| Clathrin | 1 | 2003 | 32 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 296 | 0.010 |
Why?
|
| Lymphoma | 1 | 2004 | 253 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2004 | 357 | 0.010 |
Why?
|
| Dynamins | 1 | 2003 | 50 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 372 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 367 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1983 | 252 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 197 | 0.010 |
Why?
|
| Myeloma Proteins | 1 | 1982 | 39 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 309 | 0.010 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2001 | 7 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1990 | 1730 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 398 | 0.010 |
Why?
|
| Vero Cells | 1 | 2001 | 106 | 0.010 |
Why?
|
| Herpesvirus 2, Human | 1 | 2001 | 45 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 82 | 0.010 |
Why?
|
| Rubidium | 1 | 2001 | 9 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2001 | 19 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 2001 | 11 | 0.010 |
Why?
|
| Drug Resistance, Multiple | 1 | 2001 | 20 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1982 | 142 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 2001 | 17 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1981 | 44 | 0.010 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2001 | 10 | 0.010 |
Why?
|
| Agammaglobulinemia | 1 | 1981 | 20 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 64 | 0.010 |
Why?
|
| Vincristine | 1 | 2001 | 101 | 0.010 |
Why?
|
| Fluorescence | 1 | 1981 | 103 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 2342 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1980 | 18 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2001 | 84 | 0.010 |
Why?
|
| Chondrocytes | 1 | 2001 | 66 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1980 | 78 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2001 | 112 | 0.010 |
Why?
|
| Pyridinium Compounds | 1 | 2000 | 10 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2001 | 272 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 2000 | 3 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1982 | 270 | 0.010 |
Why?
|
| Antithrombin III | 1 | 2000 | 9 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2000 | 82 | 0.010 |
Why?
|
| Idoxuridine | 1 | 2000 | 16 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 2000 | 15 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 3993 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1980 | 181 | 0.010 |
Why?
|
| Virion | 1 | 2000 | 62 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2000 | 104 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 138 | 0.010 |
Why?
|
| Fetus | 1 | 1980 | 239 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1670 | 0.010 |
Why?
|
| Munchausen Syndrome | 1 | 1979 | 2 | 0.010 |
Why?
|
| Immunity | 1 | 1980 | 155 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2001 | 245 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2000 | 193 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2001 | 270 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2001 | 480 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 306 | 0.010 |
Why?
|
| Mouth | 1 | 1979 | 49 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 1998 | 14 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2000 | 155 | 0.010 |
Why?
|
| Cholic Acids | 1 | 1998 | 7 | 0.010 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 1998 | 2 | 0.010 |
Why?
|
| Gamma Rays | 1 | 1998 | 73 | 0.010 |
Why?
|
| Cell Nucleolus | 1 | 1998 | 25 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1998 | 26 | 0.010 |
Why?
|
| Trypsin Inhibitors | 1 | 1998 | 6 | 0.010 |
Why?
|
| Tryptases | 1 | 1998 | 11 | 0.010 |
Why?
|
| Abscess | 1 | 1979 | 94 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 262 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1998 | 128 | 0.010 |
Why?
|
| Lupus Coagulation Inhibitor | 2 | 1989 | 7 | 0.010 |
Why?
|
| Microinjections | 1 | 1998 | 71 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1998 | 27 | 0.010 |
Why?
|
| Trypsin | 1 | 1998 | 95 | 0.010 |
Why?
|
| Dextrans | 1 | 1998 | 78 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1998 | 15 | 0.010 |
Why?
|
| Blood Coagulation Factors | 2 | 1989 | 20 | 0.010 |
Why?
|
| Infectious Mononucleosis | 1 | 1998 | 6 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 168 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1998 | 245 | 0.010 |
Why?
|
| Mast Cells | 1 | 1998 | 97 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1998 | 134 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 148 | 0.010 |
Why?
|
| Virus Cultivation | 1 | 1997 | 18 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1662 | 0.010 |
Why?
|
| Solubility | 1 | 1998 | 190 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1998 | 329 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1998 | 436 | 0.010 |
Why?
|
| Blood Donors | 1 | 1997 | 24 | 0.010 |
Why?
|
| Middle Aged | 5 | 1999 | 28300 | 0.010 |
Why?
|
| Rheumatic Diseases | 1 | 1997 | 30 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2003 | 1127 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1997 | 91 | 0.010 |
Why?
|
| Lamins | 1 | 1996 | 6 | 0.010 |
Why?
|
| Caspase 6 | 1 | 1996 | 3 | 0.010 |
Why?
|
| Regression Analysis | 2 | 1991 | 600 | 0.010 |
Why?
|
| Staurosporine | 1 | 1996 | 34 | 0.010 |
Why?
|
| Alkaloids | 1 | 1996 | 47 | 0.010 |
Why?
|
| Lamin Type A | 1 | 1996 | 26 | 0.010 |
Why?
|
| Aged | 2 | 1999 | 20928 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 394 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 422 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1996 | 111 | 0.010 |
Why?
|
| Aurintricarboxylic Acid | 1 | 1994 | 1 | 0.010 |
Why?
|
| Sulfones | 1 | 1994 | 46 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 257 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1176 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1981 | 3970 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2000 | 882 | 0.010 |
Why?
|
| Pregnancy | 1 | 1980 | 3239 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 1798 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 2042 | 0.010 |
Why?
|
| Child | 2 | 1981 | 7622 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 9228 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1991 | 12 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 4375 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 1991 | 95 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1991 | 66 | 0.000 |
Why?
|
| Sclerosis | 1 | 1990 | 32 | 0.000 |
Why?
|
| Hypercholesterolemia | 1 | 1991 | 161 | 0.000 |
Why?
|
| Hypoprothrombinemias | 1 | 1989 | 1 | 0.000 |
Why?
|
| Vitamin B 12 | 1 | 1989 | 24 | 0.000 |
Why?
|
| Aspirin | 1 | 1989 | 169 | 0.000 |
Why?
|
| Adolescent | 1 | 1981 | 9880 | 0.000 |
Why?
|
| Retinal Artery | 1 | 1987 | 3 | 0.000 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1987 | 111 | 0.000 |
Why?
|
| Bicarbonates | 1 | 1984 | 58 | 0.000 |
Why?
|
| Immune Sera | 1 | 1983 | 53 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1990 | 2611 | 0.000 |
Why?
|
| Enkephalin, Methionine | 1 | 1983 | 5 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1983 | 89 | 0.000 |
Why?
|
| Infant | 1 | 1990 | 3360 | 0.000 |
Why?
|
| Naloxone | 1 | 1983 | 72 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1997 | 10308 | 0.000 |
Why?
|
| Thigh | 1 | 1979 | 41 | 0.000 |
Why?
|
| Saliva | 1 | 1979 | 128 | 0.000 |
Why?
|
| Recurrence | 1 | 1979 | 1231 | 0.000 |
Why?
|